Vow ASA: Second newbuild contract confirmed
Oslo, 3 October 2024 | Vow ASA (OSE ticker: VOW) is pleased to announce that the option to deliver equipment to an unnamed second cruise newbuild has been confirmed as a firm order.
Hailed as a break-through contract and the largest to date when the 1+1 award was announced on 31 May this year (see separate announcement), equipment for this second ship is valued at EUR 14.5 million. Equipment will be delivered at the shipyard in 2026.
“With these two ships, the cruise industry is taking further steps in an even more sustainable direction. They are part of a trend towards ships with more complex and more advanced equipment. The Scanship system onboard these ships, will not only prevent discharge to sea. It will also convert organic waste stream into eco-friendly bioenergy and produce stable carbon for long-term storage, said Henrik Badin, CEO of Vow ASA.
For more information, please contact
Henrik Badin, CEO, Vow ASA
Tel: + 47 90 78 98 25
Email: [email protected]
Tina Tønnessen, CFO, Vow ASA
Tel: +47 406 39 556
Email: [email protected]
About Vow
Vow and its subsidiaries Scanship, C.H. Evensen and Etia are passionate about preventing pollution. The company’s world leading solutions convert biomass and waste into valuable resources and generate clean energy for a wide range of industries.
Advanced technologies and solutions from Vow enable industry decarbonisation and material recycling. Biomass, sewage sludge, plastic waste and end-of-life tyres can be converted into clean energy, low carbon fuels and renewable carbon that replace natural gas, petroleum products and fossil carbon. The solutions are scalable, standardised, patented, and thoroughly documented, and the company’s capability to deliver is well proven.
The company is a cruise market leader in wastewater purification and valorisation of waste. It also has strong niche positions in food safety and in heat-intensive industries with a strong decarbonising agenda.
Located in Oslo, the parent company Vow ASA is listed on the Oslo Stock Exchange (ticker VOW).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
- World War II Fighter Wreck of America's Top Ace Recovered from Jungles of Papua New Guinea
- REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share